Access to life-saving dexamethasone will be expanded to some 4.5 million COVID-19 patients in low- and middle-income countries through an advance bulk purchase of the drug in bulk, UNITAID has said. The move is the first concrete step by a global health agency under the umbrella of the WHO ACT accelerator partnership to boost access […] Continue reading ->
A slew of new and repurposed public health technology has been rapidly developed in the wake of the COVID-19 pandemic. But in the whirlwind of contact tracing apps, artificial intelligence, and location tracking being used for public health surveillance, old ethical dilemmas have resurfaced around who is actually benefiting from these technologies.  “The question remains; […] Continue reading ->
A novel study published in preprint form by Harvard University suggests that cases of the novel SARS-COV-2 virus that has caused a global pandemic may have begun appearing in Wuhan hospitals as early as August 2019 – several months before China officially admitted that a new coronavirus was circulating. The study Tuesday found an unusual […] Continue reading ->
In a series of flip-flops on Friday, the United Kingdom suspended the enrollment of new patients into the hydroxychloroquine arm of its massive RECOVERY trial, one of the largest randomised COVID-19 clinical trials in the world, after preliminary data showed “no benefit” for COVID-19 patients receiving the drug. The suspension of the trial came just […] Continue reading ->
A day ahead of a major pledging event, Gavi-the Vaccine Alliance has received some US $70 million in pledges from a broad range of corporations, foundations, initiatives and individual philanthropists to modernise, streamline and strengthen its delivery of vaccines to children in the world’s poorest countries over the next 15 years. Meanwhile, Médecins sans Frontières […] Continue reading ->